6.65BMarket Cap14.98P/E (TTM)
3.190High3.120Low7.41KVolume3.120Open3.250Pre Close23.61KTurnover0.00%Turnover Ratio14.98P/E (Static)2.08BShares13.25052wk High1.19P/B6.65BFloat Cap3.12052wk Low--Dividend TTM2.08BShs Float38.000Historical High--Div YieldTTM2.15%Amplitude3.120Historical Low3.186Avg Price1Lot Size
WUXI BIOLGCS ADR Stock Forum
China's State Council on further foreign capital attractions:
To expand access to foreign financial institutions in the banking and insurance sectors.
To expand the business scope for the domestic bond market, allow foreign financial institutions to underwrite onshore bonds.
To expand pilot projects for Limited Partners...
HSI Opens 109 pts Lower as WUXI Series Slip
$WUXI APPTEC(02359.HK)$ , whose net profit rose 21% in 2023, delayed two placing-funded investment projects by 2 years to the end of 2025, and its share price lost 2.8% to $41.55, while its sa...
HKD505.7M Southbound Trading Net Outflow from MEITUAN-W
There was HKD505.7 million, HKD372.6 million and HKD147.1 million Southbound Trading net outflow from $MEITUAN-W(03690.HK)$ , $TENCENT(00700.HK)$ and $CNOOC(00883.HK)$ .
For $SH->HK Connect(GangGuTong.HK)$ , $BANK OF CHINA(03988.HK)$ was the most active stock with highest net inflow of ...
$WUXI APPTEC(02359.HK)$ tumbled by 5% and $WUXI BIO(02269.HK)$ was down 6.7%. Biotechnology Innovation Organization revised the announcement to WuXi Apptec proactively ending its relationship with BIO.
The share price of Wuxi AppTec once tumbled by over 8% in Hong Kong on Thursday.
$WUXI BIO(02269.HK)$$WUXI APPTEC(02359.HK)$
Wuxi Bio's share price extended further decline to 21% in HK in the afternoon session.
The company reiterated that it is not a subsidiary of WUXI Apptec and does not have a human genomics business, nor does it collect human genomic data in any of its businesses.
$WUXI BIO(02269.HK)$$WUXI APPTEC(02359.HK)$
Who is Making Money From Recent Slump
Proposed Bill
False Claim in Proposed Bill
Wuxi Bio had clarified its CEO false claim - he only ever given a one-time guest lecturer back to 2013!
Incorrect Info In Proposed Bill
Wuxi Bio had clarified that that it is not subsidiary of Wuxi Ming Kand. So, the congrssman needs to amend their proposal!
No comment yet